These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23719086)

  • 1. Susceptibility of enterococci to daptomycin is dependent upon testing methodology.
    Bryant KA; Roberts AL; Rupp ME; Anderson JR; Lyden ER; Fey PD; Van Schooneveld TC
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):497-501. PubMed ID: 23719086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic evaluation of commercial susceptibility testing methods for determining the in vitro activity of daptomycin versus Staphylococcus aureus and Enterococci.
    Kirn TJ; Onyeaso E; Syed M; Weinstein MP
    J Clin Microbiol; 2014 Jun; 52(6):1877-82. PubMed ID: 24648560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False daptomycin-nonsusceptible MIC results by Microscan panel PC 29 relative to Etest results for Staphylococcus aureus and enterococci.
    Palavecino EL; Burnell JM
    J Clin Microbiol; 2013 Jan; 51(1):281-3. PubMed ID: 23077121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo daptomycin-nonsusceptible enterococcal infections.
    Kelesidis T; Humphries R; Uslan DZ; Pegues D
    Emerg Infect Dis; 2012 Apr; 18(4):674-6. PubMed ID: 22469288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010).
    Sader HS; Moet GJ; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):412-6. PubMed ID: 21546202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin-resistant Enterococcus spp.: validation of susceptibility testing and in vitro activity of vancomycin, linezolid, tigecycline and daptomycin.
    Rathe M; Kristensen L; Ellermann-Eriksen S; Thomsen MK; Schumacher H
    APMIS; 2010 Jan; 118(1):66-73. PubMed ID: 20041873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of daptomycin against isolates of Staphylococcus aureus and enterococci: first results from Turkey.
    Arslan H; Azap OK; Ergin F; Karaman SO; Oruç E
    Int J Antimicrob Agents; 2004 Jun; 23(6):642-3. PubMed ID: 15194140
    [No Abstract]   [Full Text] [Related]  

  • 8. A single-center experience with infections due to daptomycin-nonsusceptible Enterococcus faecium in liver transplant recipients.
    Lewis JD; Enfield KB; Cox HL; Mathers AJ; Sifri CD
    Transpl Infect Dis; 2016 Jun; 18(3):341-53. PubMed ID: 26953719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China.
    Sun H; Wang H; Xu Y; Jones RN; Costello AJ; Liu Y; Li G; Chen M; Mendes RE
    Diagn Microbiol Infect Dis; 2012 Dec; 74(4):399-403. PubMed ID: 23099304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of Daptomycin MIC Values for Enterococcus faecium When Measured by Reference Broth Microdilution and Gradient Diffusion Tests.
    Campeau SA; Schuetz AN; Kohner P; Arias CA; Hemarajata P; Bard JD; Humphries RM
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel clone, ST736, among Enterococcus faecium clinical isolates and its association with daptomycin nonsusceptibility.
    Wang G; Kamalakaran S; Dhand A; Huang W; Ojaimi C; Zhuge J; Yee LL; Mayigowda P; Surendraiah PK; Dimitrova N; Fallon JT
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4848-54. PubMed ID: 24913170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of two commercial susceptibility test methods for determination of daptomycin MICs.
    Jorgensen JH; Crawford SA
    J Clin Microbiol; 2006 Jun; 44(6):2126-9. PubMed ID: 16757608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Tedizolid
    Carvalhaes CG; Sader HS; Flamm RK; Streit JM; Mendes RE
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daptomycin: A viable therapeutic option for vancomycin-resistant enterococcal urinary-tract infections in Indian medical settings?
    Mohan B; Garg S; Appannanavar SB; Taneja N
    Indian J Med Microbiol; 2016; 34(3):398-9. PubMed ID: 27514977
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004).
    Sader HS; Streit JM; Fritsche TR; Jones RN
    Clin Microbiol Infect; 2006 Sep; 12(9):844-52. PubMed ID: 16882289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of testing methods for detection of decreased linezolid susceptibility due to G2576T mutation of the 23S rRNA gene in Enterococcus faecium and Enterococcus faecalis.
    Qi C; Zheng X; Obias A; Scheetz MH; Malczynski M; Warren JR
    J Clin Microbiol; 2006 Mar; 44(3):1098-100. PubMed ID: 16517903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates.
    Jevitt LA; Thorne GM; Traczewski MM; Jones RN; McGowan JE; Tenover FC; Brown SD
    J Clin Microbiol; 2006 Sep; 44(9):3098-104. PubMed ID: 16954233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of Daptomycin against Enterococcus faecium and Enterococcus faecalis in the Murine Thigh Infection Model.
    Kidd JM; Abdelraouf K; Asempa TE; Humphries RM; Nicolau DP
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo daptomycin nonsusceptibility in a clinical isolate.
    Lesho EP; Wortmann GW; Craft D; Moran KA
    J Clin Microbiol; 2006 Feb; 44(2):673. PubMed ID: 16455945
    [No Abstract]   [Full Text] [Related]  

  • 20. Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.
    Lewis JS; Owens A; Cadena J; Sabol K; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1664-5. PubMed ID: 15793168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.